ID FXL15_HUMAN Reviewed; 300 AA. AC Q9H469; A1L4J8; B1AKX8; B1AKX9; B1AKY0; B1AKY1; C9JWA4; Q0D2Q3; Q49AL7; AC Q5JWA5; DT 31-AUG-2004, integrated into UniProtKB/Swiss-Prot. DT 16-JUN-2009, sequence version 2. DT 10-JUN-2026, entry version 182. DE RecName: Full=F-box/LRR-repeat protein 15; DE AltName: Full=F-box only protein 37; GN Name=FBXL15; Synonyms=FBXO37; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164054; DOI=10.1038/nature02462; RA Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L., RA Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K., RA Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L., RA Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P., RA Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P., RA Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N., RA Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A., RA Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C., RA Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D., RA Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C., RA Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K., RA Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A., RA Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S., RA McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S., RA Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., RA Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., RA Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., RA Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A., RA Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P., RA Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y., RA Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D., RA Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.; RT "The DNA sequence and comparative analysis of human chromosome 10."; RL Nature 429:375-381(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Hypothalamus, and Lung carcinoma; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN A SCF PROTEIN LIGASE RP COMPLEX, AND INTERACTION WITH SMURF1; SMURF2 AND WWP2. RX PubMed=21572392; DOI=10.1038/emboj.2011.155; RA Cui Y., He S., Xing C., Lu K., Wang J., Xing G., Meng A., Jia S., He F., RA Zhang L.; RT "SCF(FBXL15) regulates BMP signalling by directing the degradation of HECT- RT type ubiquitin ligase Smurf1."; RL EMBO J. 30:2675-2689(2011). RN [4] RP ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). CC -!- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F-box CC protein) E3 ubiquitin-protein ligase complex which mediates the CC ubiquitination and subsequent proteasomal degradation of SMURF1, CC thereby acting as a positive regulator of the BMP signaling pathway. CC Required for dorsal/ventral pattern formation and bone mass CC maintenance. Also mediates ubiquitination of SMURF2 and WWP2. CC {ECO:0000269|PubMed:21572392}. CC -!- PATHWAY: Protein modification; protein ubiquitination. CC -!- SUBUNIT: Part of the SCF (SKP1-CUL1-F-box) E3 ubiquitin-protein ligase CC complex SCF(FBXL15) composed of CUL1, SKP1, RBX1 and FBXL15. CC {ECO:0000269|PubMed:21572392}. CC -!- INTERACTION: CC Q9H469; Q9HCE7: SMURF1; NbExp=6; IntAct=EBI-6144096, EBI-976466; CC Q9H469; Q9HAU4: SMURF2; NbExp=3; IntAct=EBI-6144096, EBI-396727; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21572392}. CC -!- SIMILARITY: Belongs to the FBXL15 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH02912.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAH36120.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AL121928; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC002912; AAH02912.1; ALT_INIT; mRNA. DR EMBL; BC036120; AAH36120.1; ALT_INIT; mRNA. DR EMBL; BC130566; AAI30567.1; -; mRNA. DR CCDS; CCDS31273.1; -. DR RefSeq; NP_001374223.1; NM_001387294.1. DR RefSeq; NP_077302.3; NM_024326.3. DR AlphaFoldDB; Q9H469; -. DR SMR; Q9H469; -. DR BioGRID; 122593; 31. DR ComplexPortal; CPX-2492; SCF E3 ubiquitin ligase complex, FBXL15 variant. DR FunCoup; Q9H469; 215. DR IntAct; Q9H469; 30. DR MINT; Q9H469; -. DR STRING; 9606.ENSP00000224862; -. DR iPTMnet; Q9H469; -. DR PhosphoSitePlus; Q9H469; -. DR BioMuta; FBXL15; -. DR DMDM; 239938631; -. DR jPOST; Q9H469; -. DR MassIVE; Q9H469; -. DR PaxDb; 9606-ENSP00000224862; -. DR PeptideAtlas; Q9H469; -. DR ProteomicsDB; 80789; -. DR Pumba; Q9H469; -. DR Antibodypedia; 53264; 88 antibodies from 15 providers. DR DNASU; 79176; -. DR Ensembl; ENST00000369956.8; ENSP00000358972.3; ENSG00000107872.15. DR Ensembl; ENST00000864349.1; ENSP00000534408.1; ENSG00000107872.15. DR Ensembl; ENST00000864350.1; ENSP00000534409.1; ENSG00000107872.15. DR Ensembl; ENST00000933209.1; ENSP00000603268.1; ENSG00000107872.15. DR Ensembl; ENST00000948416.1; ENSP00000618475.1; ENSG00000107872.15. DR Ensembl; ENST00000948417.1; ENSP00000618476.1; ENSG00000107872.15. DR Ensembl; ENST00000948418.1; ENSP00000618477.1; ENSG00000107872.15. DR GeneID; 79176; -. DR KEGG; hsa:79176; -. DR MANE-Select; ENST00000369956.8; ENSP00000358972.3; NM_024326.4; NP_077302.3. DR UCSC; uc001kvk.2; human. DR AGR; HGNC:28155; -. DR ClinPGx; PA134928704; -. DR CTD; 79176; -. DR DisGeNET; 79176; -. DR GeneCards; FBXL15; -. DR HGNC; HGNC:28155; FBXL15. DR HPA; ENSG00000107872; Low tissue specificity. DR MIM; 610287; gene. DR OpenTargets; ENSG00000107872; -. DR VEuPathDB; HostDB:ENSG00000107872; -. DR eggNOG; KOG1947; Eukaryota. DR GeneTree; ENSGT00940000160250; -. DR InParanoid; Q9H469; -. DR OMA; CHRITER; -. DR OrthoDB; 27842at2759; -. DR PAN-GO; Q9H469; 2 GO annotations based on evolutionary models. DR PhylomeDB; Q9H469; -. DR PathwayCommons; Q9H469; -. DR Reactome; R-HSA-8951664; Neddylation. DR Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation. DR SignaLink; Q9H469; -. DR SIGNOR; Q9H469; -. DR UniPathway; UPA00143; -. DR Agora; ENSG00000107872; -. DR BioGRID-ORCS; 79176; 10 hits in 1194 CRISPR screens. DR ChiTaRS; FBXL15; human. DR GenomeRNAi; 79176; -. DR Pharos; Q9H469; Tbio. DR PRO; PR:Q9H469; -. DR Proteomes; UP000005640; Chromosome 10. DR RNAct; Q9H469; protein. DR Bgee; ENSG00000107872; Expressed in adenohypophysis and 128 other cell types or tissues. DR ExpressionAtlas; Q9H469; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0019005; C:SCF ubiquitin ligase complex; IDA:UniProtKB. DR GO; GO:0030282; P:bone mineralization; ISS:UniProtKB. DR GO; GO:0009953; P:dorsal/ventral pattern formation; ISS:UniProtKB. DR GO; GO:0000086; P:G2/M transition of mitotic cell cycle; IMP:UniProtKB. DR GO; GO:0030513; P:positive regulation of BMP signaling pathway; IMP:UniProtKB. DR GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB. DR GO; GO:0030510; P:regulation of BMP signaling pathway; NAS:ComplexPortal. DR GO; GO:0031146; P:SCF-dependent proteasomal ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR CDD; cd22126; F-box_FBXL15; 1. DR FunFam; 3.80.10.10:FF:000113; F-box/LRR-repeat protein 15 isoform X1; 1. DR Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1. DR InterPro; IPR036047; F-box-like_dom_sf. DR InterPro; IPR001810; F-box_dom. DR InterPro; IPR057207; FBXL15_LRR. DR InterPro; IPR006553; Leu-rich_rpt_Cys-con_subtyp. DR InterPro; IPR032675; LRR_dom_sf. DR PANTHER; PTHR13318:SF179; F-BOX_LRR-REPEAT PROTEIN 15; 1. DR PANTHER; PTHR13318; PARTNER OF PAIRED, ISOFORM B-RELATED; 1. DR Pfam; PF00646; F-box; 1. DR Pfam; PF25372; LRR_FBXL15; 1. DR SMART; SM00367; LRR_CC; 6. DR SUPFAM; SSF81383; F-box domain; 1. DR SUPFAM; SSF52047; RNI-like; 1. PE 1: Evidence at protein level; KW Acetylation; Cytoplasm; Leucine-rich repeat; Proteomics identification; KW Reference proteome; Repeat; Ubl conjugation pathway. FT CHAIN 1..300 FT /note="F-box/LRR-repeat protein 15" FT /id="PRO_0000119931" FT DOMAIN 19..66 FT /note="F-box" FT REPEAT 141..162 FT /note="LRR 1" FT REPEAT 167..188 FT /note="LRR 2" FT REPEAT 194..215 FT /note="LRR 3" FT REPEAT 220..241 FT /note="LRR 4" FT REPEAT 246..267 FT /note="LRR 5" FT REGION 113..269 FT /note="Interaction with SMURF1" FT /evidence="ECO:0000269|PubMed:21572392" FT MOD_RES 1 FT /note="N-acetylmethionine" FT /evidence="ECO:0007744|PubMed:22814378" FT CONFLICT 164 FT /note="R -> H (in Ref. 2; AAH36120)" FT /evidence="ECO:0000305" SQ SEQUENCE 300 AA; 32998 MW; 3AF8CAFDDF75D720 CRC64; MEPPMEPSGG EQEPGAVRFL DLPWEDVLLP HVLNRVPLRQ LLRLQRVSRA FRSLVQLHLA GLRRFDAAQV GPQIPRAALA RLLRDAEGLQ ELALAPCHEW LSDEDLVPVL ARNPQLRSVA LGGCGQLSRR ALGALAEGCP RLQRLSLAHC DWVDGLALRG LADRCPALEE LDLTACRQLK DEAIVYLAQR RGAGLRSLSL AVNANVGDAA VQELARNCPE LHHLDLTGCL RVGSDGVRTL AEYCPVLRSL RVRHCHHVAE SSLSRLRKRG VDIDVEPPLH QALVLLQDMA GFAPFVNLQV //